|GeoVax Labs, Inc.|
1900 Lake Park Drive
United States - Map
GeoVax Labs, Inc. operates as a biotechnology company. The companys develops vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). Its vaccines incorporate two delivery components, including a recombinant DNA and recombinant poxvirus, known as modified vaccinia Ankara, which deliver genes that encode inactivated HIV derived proteins to the immune system. The companys vaccines under development addressing the clade B subtype of the HIV virus includes GOVX-B11 and GOVX-B21 vaccines that are n Phase I clinical trials to prevent HIV infection, and to serve as a therapy for individuals who are already infected with HIV. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.
|Dr. Robert T. McNally Ph.D.,
Chief Exec. Officer, Pres and Director
|Dr. Harriet Latham Robinson Ph.D.,
Co-Founder, Chief Scientific Officer and Director
|Mr. Mark W. Reynolds CPA,
Chief Financial Officer, Principal Accounting Officer and Corp. Sec.
|Mr. Donald G. Hildebrand ,
Founder, Chairman Emeritus and Consultant
|Dr. Arban Domi Ph.D.,
Director of Vector Devel.
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|